NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD
HEXO Corp. (HEXO) has a consensus analyst rating of Hold, based on 5 analysts covering the stock. Of those, 0 recommend buying, 3 recommend holding, and 2 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
